Clinical Association of Thyroid Stimulating Hormone Receptor Antibody Levels with Disease Severity in the Chronic Inactive Stage of Graves' Orbitopathy
Young Jae Woo, Sun Young Jang, Tyler Hyung Taek Lim, Jin Sook Yoon
Korean J Ophthalmol. 2015;29(4):213-219.   Published online 2015 Jul 21     DOI:
Citations to this article as recorded by Crossref logo
Correlation between serum anti-TSH receptor autoantibodies (TRAbs) and the clinical feature of Graves’ orbitopathy
F. Nicolì, G. Lanzolla, M. Mantuano, I. Ionni, B. Mazzi, M. Leo, A. Sframeli, C. Posarelli, M. N. Maglionico, M. Figus, M. Nardi, C. Marcocci, M. Marinò
Journal of Endocrinological Investigation.2021; 44(3): 581.     CrossRef
Characterisation of human orbital fibroblasts cultivated from intraconal, nasal and central adipose tissues
Jin A Kim, Donghyuck Ahn, Bo-Yeon Kim, Yeon Jeong Choi, Hyun Jung Shin, Sun Young Jang
British Journal of Ophthalmology.2021; 105(2): 290.     CrossRef
Thyroid Eye Disease: Pathogenic Risk Factors
Thai H. Do, Alon Kahana
International Ophthalmology Clinics.2021; 61(2): 3.     CrossRef
Orbital inflammatory disorders: new knowledge, future challenges
Alon Kahana
Current Opinion in Ophthalmology.2021; 32(3): 255.     CrossRef
Combination Model of Thyrotrophin Receptor Antibody and Volumetric Orbital Apex Crowding Index as an Indicator of Dysthyroid Optic Neuropathy
Zhihong Deng, Lu Chen, Jia Tan, Sha Wang, Dan Liu, Jinwei Wang, Chengzhi Jiang, Jie Yang, Bei Xu, Ting Su
Disease Markers.2021; 2021: 1.     CrossRef
Prevalence of thyroid eye disease in Graves’ disease: A meta‐analysis and systematic review
Yip Han Chin, Cheng Han Ng, Ming Hui Lee, Jeffery Wei Heng Koh, Jolene Kiew, Samantha Peiling Yang, Gangadhara Sundar, Chin Meng Khoo
Clinical Endocrinology.2020; 93(4): 363.     CrossRef
Thyroid-associated ophthalmopathy: Emergence of teprotumumab as a promising medical therapy
Terry J. Smith
Best Practice & Research Clinical Endocrinology & Metabolism.2020; 34(1): 101383.     CrossRef
Teprotumumab for Thyroid Eye Disease
Christopher J. Hwang, Kian Eftekhari
International Ophthalmology Clinics.2020; 60(2): 47.     CrossRef
Usefulness of TSH receptor antibodies as biomarkers for Graves’ ophthalmopathy: a systematic review
S. Seo, M. Sánchez Robledo
Journal of Endocrinological Investigation.2018; 41(12): 1457.     CrossRef
Thyrotropin Receptor Antibodies—An Overview
Anupam Kotwal, Marius Stan
Ophthalmic Plastic & Reconstructive Surgery.2018; 34(4S): S20.     CrossRef
New advances in understanding thyroid-associated ophthalmopathy and the potential role for insulin-like growth factor-I receptor
Terry J Smith
F1000Research.2018; 7: 134.     CrossRef
Expression and clinical significance of connective tissue growth factor (CTGF) in Graves' ophthalmopathy
Yi-Ming Huang, Pei-Chen Chang, Shi-Bei Wu, Hui-Chuan Kau, Chieh-Chih Tsai, Catherine Jui-Ling Liu, Yau-Huei Wei
British Journal of Ophthalmology.2017; 101(5): 676.     CrossRef
Thyroid Autoimmunity: Role of Anti-thyroid Antibodies in Thyroid and Extra-Thyroidal Diseases
Eleonore Fröhlich, Richard Wahl
Frontiers in Immunology.2017;[Epub]     CrossRef
Morphological Diversity of Pretibial Myxedema and Its Mechanism of Evolving Process and Outcome: A Retrospective Study of 216 Cases
Changgui Lan, Yi Wang, Xia Zeng, Jing Zhao, Xiaoxi Zou
Journal of Thyroid Research.2016; 2016: 1.     CrossRef
Clinical Features of Dry Eye in Thyroid-Associated Ophthalmopathy According to Disease Activity
Jun Young Ha, Won Choi, Kyung Chul Yoon
Journal of the Korean Ophthalmological Society.2016; 57(7): 1037.     CrossRef